Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

T-cell-mediated responses against the liver-stage of Plasmodium falciparum are critical for protection in the human irradiated sporozoite model and several animal models. Heterologous prime-boost approaches, employing plasmid DNA and viral vector delivery of malarial DNA sequences, have proved parti...

書目詳細資料
Main Authors:	Gilbert, S, Moorthy, V, Andrews, L, Pathan, A, McConkey, S, Vuola, J, Keating, S, Berthoud, T, Webster, D, Mcshane, H, Hill, A
格式:	Journal article
語言:	English
出版:	2006

相似書籍

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
由: Keating, S, et al.
出版: (2005)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
由: Vuola, J, et al.
出版: (2005)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
由: Dunachie, S, et al.
出版: (2006)

Prime-boost immunisation strategies for tuberculosis.
由: Mcshane, H, et al.
出版: (2005)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
由: Mcshane, H, et al.
出版: (2005)

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.
由: Hanke, T, et al.
出版: (1998)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
由: Fletcher, H, et al.
出版: (2008)

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
由: Sheehan, S, et al.
出版: (2015)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
由: Whelan, K, et al.
出版: (2009)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
由: Mcshane, H, et al.
出版: (2001)

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
由: Moorthy, V, et al.
出版: (2004)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
由: Sander, C, et al.
出版: (2009)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
由: McShane, H, et al.
出版: (2004)

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
由: Verreck, F, et al.
出版: (2009)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
由: Mcshane, H
出版: (2008)

Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa.
由: Nkolola, J, et al.
出版: (2004)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
由: Dean, G, et al.
出版: (2014)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
由: McConkey, S, et al.
出版: (2003)

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
由: Webster, D, et al.
出版: (2005)

Prime-boost immunization strategies for infectious diseases.
由: Mcshane, H
出版: (2002)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
由: Mcshane, H, et al.
出版: (2016)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
由: Brookes, R, et al.
出版: (2008)

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.
由: Taracha, E, et al.
出版: (2003)

Prime-boost strategies for malaria vaccine development.
由: Dunachie, S, et al.
出版: (2003)

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS.
由: Hanke, T, et al.
出版: (1999)

Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
由: Ibanga, H, et al.
出版: (2006)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
由: Sander, C, et al.
出版: (2005)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
由: Griffiths, K, et al.
出版: (2011)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel mycobacterium tuberculosis vaccine MVA85A
由: Griffiths, K, et al.
出版: (2011)

Evaluation of prime boosting vaccination strategy using newly constructed tuberculosis vaccine candidates in mice
由: Zakaria, Nurazwana
出版: (2013)

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
由: Rampling, T, et al.
出版: (2015)

HETEROLOGOUS PRIME-BOOST VACCINATION WITH ADCH63 AND MVA EXPRESSING MSP1 CAN INDUCE PROTECTIVE EFFICACY AGAINST SPOROZOITE CHALLENGE IN VOLUNTEERS
由: Sheehy, S, et al.
出版: (2010)

Prime-boost vectored malaria vaccines: progress and prospects.
由: Hill, A, et al.
出版: (2010)

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
由: Ewer (nee Russell), K, et al.
出版: (2016)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
由: de Cassan, S, et al.
出版: (2010)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
由: Hill, A, et al.
出版: (2000)

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
由: Wilkie, M, et al.
出版: (2019)

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
由: Cavenaugh, J, et al.
出版: (2011)

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
由: Swadling, L, et al.
出版: (2014)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
由: Draper, S, et al.
出版: (2005)